Biogen
Phone: +1 781-464-2000
| Formerly | Biogen Idec Inc. (2003–2015) |
|---|---|
| Type | Public company |
| Traded as |
|
| Industry | Biotechnology |
| Founded | 1978 (1978) |
| Founders | Kenneth Murray Phillip Allen Sharp Walter Gilbert Heinz Schaller Charles Weissmann |
| Headquarters | Cambridge, Massachusetts, U.S. |
| Key people | Stelios Papadopoulos (Chairman) Michel Vounatsos (CEO) |
| Products | Avonex, Fampyra, Plegridy, Tecfidera, Tysabri, Spinraza |
| Revenue |  US$10.981 billion (2021) |
| Operating income | US$2.84 billion (2021) |
| Net income | US$1.727 billion (2021) |
| Total assets | US$23.877 billion (2021) |
| Total equity |  US$10.96 billion (2021) |
| Number of employees | 9,100 (2020) |
| Website | biogen.com |
At Biogen, our mission is clear: we are pioneers in neuroscience. Since our founding in 1978 as one of the world’s first global biotechnology companies, Biogen has led innovative scientific research with the goal over the last decade to defeat devastating neurological diseases.
For detailed contact information visit location pages below.
Biogen's locations around the world
Europe
North America
Oceania
Clinical Trials sponsored by Biogen
-
Biogen招聘中
-
Biogen主动，不招人脊髓性肌萎缩症美国, 匈牙利, 日本, 意大利, 德国
-
Biogen邀请报名亚急性皮肤红斑狼疮 | 慢性皮肤红斑狼疮美国, 巴西, 西班牙, 台湾, 加拿大, 法国, 德国, 日本, 意大利, 哥伦比亚, 英国, 塞尔维亚, 智利, 菲律宾, 保加利亚, 中国, 瑞典, 瑞士, 墨西哥, 韩国, 阿根廷, 匈牙利, 斯洛伐克, 波兰, 葡萄牙